Symptomtext
The first reaction was the same day on the second dose given on January 22, 2021 (Manufacturer: Moderna). Reactions were heart palpitations, high blood pressure, Shortness of breath, and tagitue. The next day left neck nodule swelled and developed photophobia. The consequence of the reaction was with medical provider with follow-up. The second reaction event was the covid booster Administered on July 7, 2022 (Manufacturer: Pfizer, Inc). On August 3, 2022. I had symptoms of Covid and experienced increased photophobia and fatigue. September 2022-present and continue with follow-up with specialists ophthalmologist for Strabismus.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Moderna second does labs and test. -CHEMISTRY PANEL May 14, 2021. -EKG 12 OR MORE LEADS W INT & APT May 14, 2021. FRACTION OF URINE CATECHOLAMINES Aug 2, 2021. -24 HOUR URINE METANEPHRINES FRACTIONATED METANEPHRINES Aug 4, 2021 -EKG 12 OR MORE LEADS 2 INT & APT Aug 2, 2021. Primary/active Event: Covid booster (Pfizer COVID-19 tris vaccn(PF)) Administered on Jul 7, 2022 Manufacturer; Pfizer, Inc Product Pfizer COVID-19 tris vaccn (PF) Lot# FM9992-PFIZER-2021 NDC: 59267-10251 Dose: 0.3mL Route intramuscular Site Right Detltoid Labs and tests after Covid booster (Pfizer COVID-19 tris Vaccn (PF)) -CT ANGIOGRAM NECK Dec 13, 2022 -CT ANGIOGRAM HEAD Dec 13, 2022 -CHEMISTRY PANEL Dec 12, 2022 -RERYTHROCYTE SEDIMENTATION RATE (ESR) Dec 6, 2022 -C REACTIVE PROTEITN Dec 6, 2022 -CBC (COMPLETE BLOOD COUNT) Dec 6, 2022 -HEMOGLOBIN Nov 30, 2022 -THYROID STIMULATING HORMONE Nov 30, 2022 -MYASTHENIA GRAVIS ANTIBODY PANEL Nov 30, 2022 -MRI BRAIN AND BRAINSTEM Nov 23, 2022
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None ( before theCovid Vacciation)
- Andere Medikamente
- None
- Allergien
- nNone
- Vorherige Impfungen
- -